Free Trial
TSE:FTR

Field Trip Health (FTR) Stock Price, News & Analysis

About Field Trip Health Stock (TSE:FTR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Field Trip Health and its competitors with MarketBeat's FREE daily newsletter.

FTR Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
UW Health strike averted on eve of walkout
See More Headlines

FTR Stock Analysis - Frequently Asked Questions

Shares of FTR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Field Trip Health investors own include QuantumScape (QS), Camber Energy (CEI), CAMP4 Therapeutics (CAMP), Siren Nasdaq NexGen Economy ETF (BLCN), Bioanalytical Systems (BASI), Atomera (ATOM) and Athersys (ATHX).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Telephone Communications
Sub-Industry
Communication
Current Symbol
TSE:FTR
CIK
N/A
Web
N/A
Fax
N/A
Employees
14,700
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (TSE:FTR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners